Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,13450,1089,0.64 [0.55-0.75],6.275509843752267e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,16908,1665,0.55 [0.49-0.62],2.5211422104608777e-22
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,21632,648,1.51 [1.26-1.81],1.0494096933179556e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Peripheral artery disease,21753,170,0.45 [0.32-0.63],3.618096799560239e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,21178,785,0.49 [0.41-0.58],3.25420544487794e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,21152,759,0.47 [0.40-0.56],2.6423962866257377e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,16725,1482,0.52 [0.46-0.59],4.623224362809472e-24
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15435,192,0.55 [0.40-0.76],0.0003364158339628
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,16615,1372,0.52 [0.45-0.59],1.7267852381326985e-23
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Neurological diseases,18995,1516,0.76 [0.68-0.86],1.781441191828561e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22037,476,0.64 [0.52-0.79],2.588356468507328e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22195,120,0.47 [0.32-0.70],0.000158288795883
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,14401,4620,0.57 [0.52-0.63],9.922805581650282e-35
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Hypertension, essential",15267,3243,0.59 [0.53-0.65],5.1112080645443215e-27
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypertension,15311,3287,0.60 [0.54-0.66],4.0865666360079495e-26
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",20474,1844,0.55 [0.50-0.62],5.441069792389693e-25
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Angina pectoris,19727,1097,0.56 [0.49-0.64],5.459175481842947e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21985,349,0.66 [0.51-0.83],0.0006237204243267
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22337,701,0.56 [0.47-0.67],3.9923590511711395e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19066,436,0.47 [0.38-0.58],1.96083134717655e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,20101,1496,0.50 [0.45-0.57],4.3509489180597715e-28
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Heart failure, strict",21720,295,0.63 [0.48-0.82],0.0005082208150253
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21727,108,0.46 [0.30-0.70],0.0002855172380416
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,21797,178,0.42 [0.30-0.58],1.7324186174843589e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,17233,2173,0.64 [0.57-0.71],8.782527181216346e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22096,290,0.56 [0.43-0.73],1.8568134236532936e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22087,281,0.56 [0.43-0.73],2.013476616459523e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,20249,1147,0.67 [0.58-0.77],1.251365843088154e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Early onset COPD,21709,246,0.53 [0.40-0.70],1.0328302719377978e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",21762,299,0.54 [0.42-0.70],2.443839109973926e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",21762,299,0.54 [0.42-0.70],2.443839109973926e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",21674,873,0.74 [0.64-0.87],0.0001898718600423
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Asthma,15207,873,0.64 [0.55-0.75],7.52012142748023e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",14810,873,0.64 [0.54-0.75],4.7327878634963975e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",15198,864,0.64 [0.54-0.75],6.772875084411172e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,22810,125,0.45 [0.30-0.66],4.364979427014412e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Interstitial lung disease,21725,97,0.36 [0.23-0.56],4.670748449675456e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",22907,97,0.37 [0.24-0.57],5.58713414508572e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21718,90,0.38 [0.24-0.60],3.337554158022817e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other diseases of pleura,20701,299,0.62 [0.48-0.80],0.0002827317874212
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,15095,6518,0.81 [0.75-0.87],5.2389347602298244e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Hernia,19723,2095,0.68 [0.62-0.76],1.3841139414653442e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Inguinal hernia,18430,802,0.46 [0.39-0.54],5.352099620946872e-22
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,21727,215,0.59 [0.44-0.80],0.0006506227901785
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,GI-bleeding,21718,206,0.57 [0.42-0.77],0.0003124005718199
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22318,393,0.61 [0.48-0.77],2.232602295521582e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22206,281,0.55 [0.42-0.72],1.6101872173102536e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19608,300,0.61 [0.47-0.79],0.0001532501957985
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23005,252,0.53 [0.40-0.70],7.491138111564427e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22940,187,0.56 [0.40-0.77],0.0003958876279942
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,19567,372,0.64 [0.51-0.82],0.0002626570317156
